Crescentis Capital Ltd Upgraded to Sell on Improved Technicals Despite Weak Financials

Quality Assessment: Persistent Weakness Amid Operating Losses

The quality of Crescentis Capital’s financial health remains a significant concern. The company reported a dismal quarter in Q4 FY25-26, with operating losses deepening. Its Profit After Tax (PAT) for the quarter stood at a negative ₹7.35 crores, marking a staggering fall of 10,600% compared to the previous four-quarter average. Earnings before interest, taxes, depreciation and amortisation (EBITDA) were also negative at ₹-2.94 crores, underscoring operational challenges.

Further, the Profit Before Depreciation, Interest and Taxes (PBDIT) and Profit Before Tax less Other Income (PBT less OI) were at their lowest levels, ₹-8.79 crores and ₹-8.93 crores respectively. These figures highlight the company’s weak long-term fundamental strength, which remains a critical factor in the overall downgrade from Strong Sell to Sell despite other improvements.

Valuation: Risky Trading Amid Historical Volatility

Crescentis Capital is classified as a micro-cap stock, trading at ₹123.80 as of the latest close, down 0.80% from the previous day’s ₹124.80. The stock’s 52-week range is wide, with a low of ₹81.05 and a high of ₹172.03, indicating significant price volatility. Despite this, the stock has delivered a remarkable 43.20% return over the past year, outperforming the BSE500 index’s modest 0.51% gain in the same period.

However, this strong price performance contrasts with the company’s negative earnings and operating losses, suggesting that the stock is trading at risky valuations relative to its historical averages. The MarketsMOJO Mojo Score remains low at 31.0, with a Mojo Grade of Sell, reflecting cautious sentiment among market analysts. This valuation risk tempers enthusiasm and supports the decision to maintain a Sell rating rather than upgrade further.

Financial Trend: Negative Earnings Offset by Market-Beating Returns

Financially, Crescentis Capital’s recent quarterly results paint a bleak picture. The company’s operating losses and negative EBITDA indicate deteriorating profitability. Yet, paradoxically, the stock has generated strong returns over multiple time horizons. Year-to-date, the stock has risen 4.43%, while the Sensex has declined by 9.54%. Over one year, the stock’s return of 43.20% vastly outpaces the Sensex’s negative 6.45% return.

Longer-term returns are more mixed. Over three years, the stock has declined by 51.23%, significantly underperforming the Sensex’s 21.91% gain. However, over five and ten years, Crescentis Capital has delivered extraordinary returns of 374.33% and 2,244.70% respectively, dwarfing the Sensex’s 46.60% and 188.03% gains. This divergence between financial performance and stock price suggests speculative interest or other market factors influencing valuation.

Technicals: Bullish Momentum Drives Upgrade

The primary driver behind the upgrade from Strong Sell to Sell is the marked improvement in technical indicators. The technical grade has shifted from mildly bullish to bullish, signalling a more positive near-term price outlook. Key technical metrics include:

• MACD: Both weekly and monthly Moving Average Convergence Divergence indicators are bullish, indicating upward momentum.
• Bollinger Bands: Weekly and monthly readings are bullish, suggesting price strength and potential breakout.
• Moving Averages: Daily moving averages are bullish, reinforcing short-term positive trends.

However, some indicators remain mixed or neutral. The Relative Strength Index (RSI) on weekly and monthly charts shows no clear signal, while the Know Sure Thing (KST) indicator remains mildly bearish on weekly and monthly timeframes. Dow Theory analysis also indicates no definitive trend on weekly or monthly scales. Despite these nuances, the overall technical picture has improved sufficiently to warrant a more optimistic rating.

Market Context and Shareholding

Crescentis Capital operates within the NBFC sector, a segment often sensitive to economic cycles and credit conditions. The company’s promoter group remains the majority shareholder, which may provide some stability amid market volatility. Nevertheless, the micro-cap status and negative earnings profile keep the stock in a higher risk category for investors.

Conclusion: Cautious Optimism Amid Structural Challenges

The upgrade of Crescentis Capital Ltd’s investment rating from Strong Sell to Sell reflects a cautious optimism driven primarily by improved technical indicators. While the company’s financial fundamentals remain weak, with significant operating losses and negative EBITDA, the stock’s recent price performance and bullish technical signals have tempered the outlook.

Investors should weigh the risks of the company’s weak earnings and volatile valuation against the potential for technical-driven price gains. The micro-cap status and sector-specific challenges in the NBFC space further underscore the need for careful consideration. Overall, the Sell rating suggests that while the stock may be stabilising, it is not yet positioned for a definitive turnaround.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today